相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Natural antitubulin agents: Importance of 3,4,5-trimethoxyphenyl fragment
Arvind S. Negi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Rapid synthesis of 4-arylchromenes from ortho-substituted alkynols: A versatile access to restricted isocombretastatin A-4 analogues as antitumor agents
Dolor Renko et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Therapeutic Modalities of Squalenoyl Nanocomposites in Colon Cancer: An Ongoing Search for Improved Efficacy
Andrei Maksimenko et al.
ACS NANO (2014)
Effects of the Tumor-Vasculature-Disrupting Agent Verubulin and Two Heteroaryl Analogues on Cancer Cells, Endothelial Cells, and Blood Vessels
Katharina Mahal et al.
CHEMMEDCHEM (2014)
Discovery of azaisoerianin derivatives as potential antitumors agents
Mohamed Ali Soussi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery and Hit to Lead Optimization of Novel Combretastatin A-4 Analogues: Dependence of C-Linker Length and Hybridization
Olivier Provot et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
Design, synthesis and anticancer properties of 5-arylbenzoxepins as conformationally restricted isocombretastatin A-4 analogs
Evelia Rasolofonjatovo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Synthesis of Ortho/Ortho′-Substituted 1,1-Diarylethylenes through Cross-Coupling Reactions of Sterically Encumbered Hydrazones and Aryl Halides
Maxime Roche et al.
JOURNAL OF ORGANIC CHEMISTRY (2013)
An efficient coupling of N-tosylhydrazones with 2-halopyridines: synthesis of 2-α-styrylpyridines endowed with antitumor activity
Marie Lawson et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2013)
Conformationnally restricted naphthalene derivatives type isocombretastatin A-4 and isoerianin analogues: Synthesis, cytotoxicity and antitubulin activity
Evelia Rasolofonjatovo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Discovery of Isoerianin Analogues as Promising Anticancer Agents
Samir Messaoudi et al.
CHEMMEDCHEM (2011)
B-Ring-Modified isoCombretastatin A-4 Analogues Endowed with Interesting Anticancer Activities
Abdallah Hamze et al.
CHEMMEDCHEM (2011)
Biological Potential and Structure-Activity Relationships of Most Recently Developed Vascular Disrupting Agents: An Overview of New Derivatives of Natural Combretastatin A-4
M. Marrelli et al.
CURRENT MEDICINAL CHEMISTRY (2011)
COMBRETASTATIN DERIVATIVES IN CANCER: RECENT RESEARCH REVIEWED
C. B. Pattillo
DRUGS OF THE FUTURE (2011)
PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions
Mats H. M. Olsson et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2011)
Palladium-catalyzed coupling of N-tosylhydrazones with ortho substituted aryl halides: synthesis of 4-arylchromenes and related heterocycles
Evelia Rasolofonjatovo et al.
TETRAHEDRON LETTERS (2011)
NWChem: A comprehensive and scalable open-source solution for large scale molecular simulations
M. Valiev et al.
COMPUTER PHYSICS COMMUNICATIONS (2010)
Synthesis, Biological Evaluation of 1,1-Diarylethylenes as a Novel Class of Antimitotic Agents
Abdallah Hamze et al.
CHEMMEDCHEM (2009)
Empirical Scoring Functions for Advanced Protein-Ligand Docking with PLANTS
Oliver Korb et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Isocombretastatins A versus Combretastatins A: The Forgotten isoCA-4 Isomer as a Highly Promising Cytotoxic and Antitubulin Agent
Samir Messaoudi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Discovery of N-(4-Methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a Potent Apoptosis Inducer and Efficacious Anticancer Agent with High Blood Brain Barrier Penetration
Nilantha Sirisoma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Synthesis and antitumor activity of benzils related to combretastatin A-4
Celiine Mousset et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
One-pot hydrosilylation-protodesilylation of functionalized diarylalkynes:: a highly selective access to Z-stilbenes.: Application to the synthesis of combretastatin A-4
Anne Giraud et al.
TETRAHEDRON LETTERS (2008)
In vitro metabolism study of combretastatin A-4 in rat and human liver Microsomes
Silvio Aprile et al.
DRUG METABOLISM AND DISPOSITION (2007)
MPC-6827: A small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps
Shailaja Kasibhatla et al.
CANCER RESEARCH (2007)
N-tosylhydrazones as reagents for cross-coupling reactions:: A route to polysubstituted olefins
José Barluenga et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
Pseudolarix acid B, a new tubulin-binding agent, inhibits angiogenesis by interacting with a novel binding site on tubulin
YG Tong et al.
MOLECULAR PHARMACOLOGY (2006)
Medicinal chemistry of combretastatin A4: Present and future directions
GC Tron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Integrated modeling program, applied chemical theory (IMPACT)
JL Banks et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-4
GR Pettit et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Further naphthylcombretastatins.: An investigation on the role of the naphthalene moiety
ABS Maya et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
In vivo and in vitro evaluation of erianin, a novel anti-anglogenic agent
YQ Gong et al.
EUROPEAN JOURNAL OF CANCER (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Mechanisms of caspase activation
KM Boatright et al.
CURRENT OPINION IN CELL BIOLOGY (2003)
Combretastatins: from natural products to drug discovery
A Cirla et al.
NATURAL PRODUCT REPORTS (2003)
Phase I clinical trial of weekly combretastatin A4 phosphate: Clinical and pharmacokinetic results
GJS Rustin et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
A fluorescence-based high-throughput assay for antimicrotubule drugs
DM Barron et al.
ANALYTICAL BIOCHEMISTRY (2003)
分享论文
